Prostarm grants 3.21 lakh ESOPs at Rs.50 each
Prostarm Info Systems Limited granted 3,21,750 stock options at Rs.50 per share under ESOP 2024. The options vest per specific conditions with no lock-in on exercised shares.

*this image is generated using AI for illustrative purposes only.
Prostarm Info Systems Limited has approved the grant of 3,21,750 Employee Stock Options to an eligible employee, including those of a subsidiary company. The decision was made by the company's Nomination and Remuneration Committee during its meeting on May 22, 2026, under the 'Prostarm Employee Stock Option Plan 2024' (ESOP 2024).
The options granted correspond to 3,21,750 equity shares of Rs.10 each. The exercise price for these options has been fixed at Rs.50 per share. The scheme is compliant with the Securities and Exchange Board of India (SBEB) Regulations, 2014, and the SEBI (SBEBSE) Regulations, 2021.
Key Details of the Grant
The following table outlines the specific details regarding the grant of options:
| Particulars | Details |
|---|---|
| Options Granted | 3,21,750 |
| Shares Covered | 3,21,750 equity shares of Rs.10 each |
| Exercise Price | Rs.50 per option |
| Vesting Period | As per grant letter and ESOP 2024 |
| Exercise Period | Within 1 year from date of vesting |
Terms and Conditions
The options granted will vest in accordance with the conditions specified in the grant letter and the ESOP 2024. There is no lock-in period applicable to the equity shares arising from the exercise of these options. Once allotted, these shares will rank pari-passu with existing equity shares of the company.
In the event of corporate actions such as a rights issue, bonus issue, sub-division, consolidation, or merger, the company will make reasonable adjustments to the number of options and/or the exercise price as per the provisions of ESOP 2024.
Historical Stock Returns for Prostarm Info Systems
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.23% | +10.46% | +3.62% | +1.84% | +25.05% | +25.05% |
How might the Rs.50 exercise price compare to Prostarm Info Systems' prevailing market price, and what does this discount (or premium) signal about management's confidence in future stock performance?
Could this ESOP grant be a precursor to Prostarm Info Systems pursuing aggressive talent acquisition or retention strategies ahead of a major business expansion or product launch?
How will the potential dilution from 3,21,750 new equity shares impact existing shareholders' ownership percentage and earnings per share if all options are exercised?


































